table of contents optimizing targeted treatment in cancer negotiating the challenges to success while driving sales growth and r&d activity oncology sector emergence will be fraught by unique developmental commercial using expert insight this brief examines strategies overcome these hurdles product code bfhc0702 price 1900 publication date 31 aug 2005 overview introduction pharmacotherapy is on cusp a paradigm shift richness targets agents has resulted from convergence scientific advances however maximizing chances rewards require developers mitigate several key clinical regulatory economic obstacles scope facing players into for improving patient selection go no decisions progressing late stage development lifecycle management case studies therapy pharmacoeconomic hindering uptake report highlights tt not entirely replace traditional cytotoxic latter continue form cornerstone co administration allow optimization
